practitioners will recognize lactational atrophic vaginitis and be able to empower women with this condition to make the best treatment decisions for themselves and their families.

While treatments for vulvovaginal atrophy have ... the BZA/CE treatment groups did not report increased adverse events, there was a significantly higher incidence of vaginitis in all three groups ...

Previously referred to as vulvovaginal atrophy or atrophic vaginitis, GSM is characterized ... including its causes, symptoms, treatment, and overall outlook for those with this condition.

The global vaginal and vulval inflammatory diseases treatment market is poised for significant growth over the next decade, driven by a rising prevalence of gynecological conditions, expanding ...